Search

everythinglearnresearchcommunity

for

Search:↓

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Polymeric nanoparticles show promise for treating skin diseases.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Calcium affects where root hairs grow, but other unknown factors determine their growth direction.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Multiple treatments work best for hair loss.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Undariopsis peterseniana extract helps hair grow by activating certain cell growth pathways and could be a new treatment for hair loss.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.